Jiang, Y., Zheng, R., & Sang, H. (2021). Cost-Effectiveness of Adding SGLT2 Inhibitors to Standard Treatment for Heart Failure With Reduced Ejection Fraction Patients in China. Frontiers Media S.A.
Chicago Style (17th ed.) CitationJiang, Yaohui, Rujie Zheng, and Haiqiang Sang. Cost-Effectiveness of Adding SGLT2 Inhibitors to Standard Treatment for Heart Failure With Reduced Ejection Fraction Patients in China. Frontiers Media S.A, 2021.
MLA (8th ed.) CitationJiang, Yaohui, et al. Cost-Effectiveness of Adding SGLT2 Inhibitors to Standard Treatment for Heart Failure With Reduced Ejection Fraction Patients in China. Frontiers Media S.A, 2021.
Warning: These citations may not always be 100% accurate.